Henderson Mary Elizabeth 4

What Happened
Mary Elizabeth Henderson, Senior Vice President, Technical Operations at Jazz Pharmaceuticals (JAZZ), disposed of 1,394 ordinary shares on March 5, 2026. The weighted-average sale price reported was $186.75 per share, for proceeds of approximately $260,325. This transaction was a sale to satisfy tax obligations arising from the vesting of previously granted restricted stock units (RSUs), not an open-market investment buy.

Key Details

• Transaction date: March 5, 2026. Filing date: March 9, 2026. (Timeliness not specified in the provided data.)
• Shares sold: 1,394; weighted-average sale price: $186.75; total proceeds ≈ $260,325.
• Reason/code: F — shares sold to satisfy tax obligations on vested RSUs (Footnote F1).
• Footnote F2: Sales were executed in multiple transactions at prices ranging $186.1633–$186.7558; the filing reports the weighted-average price and the reporting person may provide transaction-level details upon request.
• Shares owned after the transaction: not specified in the provided filing excerpt.

Context
This was a routine tax-withholding sale tied to RSU vesting (cashless/tax-satisfaction event), which is common and generally not treated as a directional insider bet on the stock. For full details or to confirm filing timeliness, check the complete Form 4 on the SEC EDGAR system.